2015-10-21 12:00 — 2015-10-21 13:30
US leadership in global health innovation has played a critical role in achieving landmark progress in global health over the past fifteen years. As the global community embarks on the next era of development, the Sustainable Development Goals (SDGs) challenge us to reach for zero and eliminate poverty, infectious disease outbreaks, and preventable maternal and child deaths.
The end of HIV/AIDs, malaria, tuberculosis, neglected tropical diseases and preventable deaths during childbirth are only within reach if we continue to invest in the research and development for new vaccines, drugs and devices that move us beyond current health interventions.
The Global Health Technologies Coalition had an interactive panel discussion on how global health innovation is key to tackling the world’s most pressing health issues and meeting the challenge of the Sustainable Development Goals. The panel highlighted the importance of partnerships, especially the role of the private sector, nonprofits and US Government in global health innovation.
A panel discussion with:
- Kaitlin Christenson, PATH
- Gary Cohen, Becton, Dickinson and Company
- Dean Jamison, Lancet Commission on Investing in Health
- Tony Pipa, US Department of State
- Moderated by Lisa Cohen, Washington Global Health Alliance
In Collaboration with:
- Senator Roger Wicker and Senator Chris Coons, co-chairs of the Senate Caucus on Malaria and Neglected Tropical Diseases
- Congressman Ander Crenshaw and Congressman Gregory Meeks, co-chairs of the Congressional Malaria and Neglected Tropical Diseases Caucus